Le Lézard

News by subject: TRI

1 2 3 4 5 6 7 8 9 10

2 july 2015

14:00
Releases of the genetically engineered Oxitec mosquito, commonly known as 'Friendly Aedes aegypti', reduced the dengue mosquito population in an area of Juazeiro, Brazil by 95%, well below the modelled threshold for epidemic disease transmission.  ...

09:00
TES Pharma and EPFL announce a new research and development collaboration on novel small molecule modulators of the kynurenine pathway as therapies for metabolic disorders and age-related diseases.      (Logo:...

07:00
AcelRx Pharmaceuticals, Inc. , a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that results from the IAP311 study have been...

05:52
Avexxin's lead compound AVX001 in a topical formulation has shown Proof-of-Concept in man in an ascending dose Phase I/IIa study encompassing 26 patients suffering from mild-to-moderate psoriasis. The independent Safety Board concluded that the...

04:00
TES Pharma and EPFL announce a new research and development collaboration on novel small molecule modulators of the kynurenine pathway as therapies for metabolic disorders and age-related diseases.      (Logo:...


1 july 2015

15:39
BiologicTx® released four-year outcomes of patients treated with desensitization therapy resulting in a successful transplant: BiologicTx® has partnered with 31 transplant programs in the United States.  Since April 2011, when BiologicTx began...

13:00
goBalto, Inc., the leading provider of cloud-based clinical study startup solutions, announced today unprecedented growth in serving pharmaceutical, biotech and CRO companies. "There is intense pressure to speed clinical trials and restrain costs,...

11:22
Staying active, never smoking and controlling diabetes and cholesterol can prevent hardening of the arteries, but effective treatment of atherosclerosis could come down to harnessing an enzyme already built in to the blood vessels. Atherosclerosis...

09:26
Lupin, Strides, HEC Group, Huahai Bring Total Number of MPP Sub-licensees to Fourteen Companies     The Medicines Patent Pool (MPP) announced the rapid expansion of its network of generic manufacturers to 14 companies now working on more than 50...

09:11
ExeGi Pharma, a company focused on developing and commercializing live biotherapeutics and probiotic treatments, announced today that it has been granted a product license by the Health Canada Natural and Non-prescription Health Products Directorate...

09:05
LabStyle Innovations Corp. (DRIO), developer of the Dariotm Diabetes Management Solution, today announced the appointment of Todd Durniak as Senior Vice President and General Manager for the U.S.  Durniak brings to LabStyle over 20 years of medical...

08:40
Continental Clinical Solutions (Continental) announced it is expanding its Baltimore-based clinical studies network and is recruiting physicians from private practice to accommodate increased volume in clinical studies and demand for unique patient...

08:30
Rock Creek Pharmaceuticals, Inc., , a drug development company focused on chronic inflammatory disease and neurologic disorders, announced today the results of a human proof of principle study with anatabine citrate, the Company's lead compound....

08:30
Neuraltus Pharmaceuticals, Inc., a privately-held biopharmaceutical company focused on the development of groundbreaking drugs to treat neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), announced today that Robert G. Miller,...

08:00
The ALS Association and the ALS Finding a Cure Foundation are pleased to announce $3 million in funding for two new Phase II clinical studies through the ALS Accelerated Therapeutics (ALS ACT) initiative. Created as a collaboration with the Northeast...

06:50
Accutest Laboratories recently completed a first-to-file study for the fixed dose combination of Memantine 28 mg ER and Donepezil hydrochloride 10 mg capsule in a record setting time of 5 days. This included volunteer screening, clinical, analytical,...

04:03
InferMed's decision support technology will augment Elsevier's evidence-based clinical solutions suite  Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced today the acquisition...


30 june 2015

20:47
In the news release, Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study, issued 30-Jun-2015 by Avanir Pharmaceuticals, Inc. over PR Newswire, we are advised by the company that there were multiple...

19:01
FOR EMEA MEDIA ONLY - NOT FOR SWISS/AUSTRIAN JOURNALISTS  Launch delivers important new treatment option for advanced thyroid cancer following significant progression-free survival data from the SELECT trial   Lenvima® (lenvatinib) is now...

12:00
Tonight [Tuesday 30 June] sees the hotly anticipated Neo-Romantic Art Gala take place at Masterpiece London, expected to raise in the region of £1m for the NSPCC. Hosted by Claudia Winkleman and Mariella Frostrup, The Neo-Romantic Art Gala in aid of...

10:11
BioLight Life Sciences Investments Ltd. , a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, announced today that its CellDetect® non-invasive test for detecting bladder cancer in urine...

09:41
Pharma Two B Ltd., a privately held company developing innovative therapeutics based on previously approved drugs, announced today the successful results of the company's Phase IIb pivotal study of P2B001 for the treatment of early stage Parkinson's...

09:18
Oramed Pharmaceuticals Inc. (http://www.oramed.com), a clinical-stage pharmaceutical Company focused on the development of oral drug delivery systems, announced today that the first patient has been screened in the Company's Phase IIb trial of its...

09:00
As demand increases for its leading IRT technology, endpoint announced a series of organizational changes to help the company better serve clients and grow its customer base. endpoint has promoted Chuck Harris to general manager. Jonathan Dole, CEO...

09:00
The Michael J. Fox Foundation for Parkinson's Research (MJFF) and The Michael Stern Parkinson's Research Foundation (MSPRF) announced today the merging of their organizations to advance cutting-edge research focused on the underlying cause, diagnosis...

09:00
Avanir Pharmaceuticals, Inc. today announced top-line data from the PRISM II study showing that treatment with NUEDEXTA® was associated with a statistically significant reduction in symptoms of pseudobulbar affect (PBA) in patients with traumatic...

08:24
- Germline biomarkers predicted drug toxicity: impact on clinical routine A core tenet of precision medicine is that predictive biomarkers can enhance therapeutic decision-making. In a new pilot study, scientists at Molecular Health analyzed a...

08:15
Oramed Pharmaceuticals Inc. (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that it has submitted the study protocol for the company's Phase IIb trial of...

08:00
Ethicon*, a leader in advancing bariatric and metabolic research for 20 years, today announced a $3.2 million investment in clinical research to better understand how earlier surgical intervention may improve conditions such as obesity and Type 2...

07:33
Improved content discoverability via Reaxys® Medicinal Chemistry combined with data integration capabilities allow chemists to identify and optimize promising lead candidates   Elsevier, a world-leading provider of scientific, technical and medical...

07:30
Aeterna Zentaris Inc. (the "Company") today announced it has reached its goal of recruiting 500 patients for its pivotal Phase 3 ZoptEC (Zoptarelin Doxorubicin in Endometrial Cancer) clinical study with zoptarelin doxorubicin in women with...

07:00
BLA for MCNA submitted electronically to the US FDA on June 29th, 2015 Manufacturing facility upgrades completed and pre-launch production planning initiated FDA waives US$2.3 million application fee for Telesta Telesta Therapeutics Inc....

07:00
RepliCel Life Sciences Inc. , a clinical stage regenerative medicine company focused on the development of autologous cell therapies, announced today that the first participant in its Phase 1/2 clinical trial of RCT-01, being tested for the...

06:56
Next generation sequencing may be able to bypass some of the downside of molecular testing and in doing so earn its place in clinical testing, according to Kalorama Information.   The healthcare market researcher said that the use of NGS in labs is...

06:00
Marken, the leading clinical trial logistics organization providing solutions and services to the life sciences industry, has been granted permission by the government to deliver the first direct to patient shipment of clinical drug product in...

06:00
Egalet Corporation ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative pain treatments, today announced top-line results from a Category 3 human abuse liability (HAL) study of...

02:00
BioClinica®, Inc., the world's leading specialty clinical trial service provider, announced today the opening of new and expanded offices in London and Munich to better serve its growing client base in Europe. The state-of-the-art facilities will...


29 june 2015

19:21
The Government of the Republic of Equatorial Guinea announced an agreement with industry partners, Marathon Oil Corporation, Noble Energy Inc. and AMPCO, to sponsor the clinical development of Sanaria® PfSPZ Vaccine against malaria, including a...

18:05
New guidelines released today by the American Heart Association and American Stroke Association give hope for better outcomes to the hundreds of thousands of patients who experience an acute ischemic stroke each year. Stryker's Trevo® Retriever was...

15:47
BiondVax Pharmaceuticals Ltd. today announced positive preliminary results from its BVX-006 Phase II clinical trial of M-001, BiondVax's candidate for a universal influenza vaccine. In this trial, M-001 was injected intramuscularly to volunteers...

15:00
Regeneron Pharmaceuticals, Inc. today announced that the Proceedings of the National Academy of Sciences (PNAS) has published a paper demonstrating that the Company's proprietary VelociGene® and VelocImmune® technologies enabled the rapid...

12:38
AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce that the impact factor of its journal, Clinical Chemistry, has increased to 7.9 in the 2014 Thomson Reuters...

11:00
BioNano Genomics, Inc., the leader in genome mapping, with a group of top research institutes, announced today that a collaboration led by the Icahn School of Medicine at Mount Sinai resulted in the creation of the first comprehensive analysis of a...

11:00
There is good news for golfers suffering from chronic low back pain and needing spinal fusion surgery. A new study by Dr. Frank Phillips, co-director of the Minimally Invasive Spine Institute at Midwest Orthopaedics at Rush and Highland Park...

10:25
WIRB-Copernicus Group® (WCGtm), the world's largest provider of regulatory and ethical review services and software to support clinical research, announced today that it will host a live, one-hour webinar entitled "New Therapeutic Innovations in...

10:00
Velano Vascular today announced that the company's novel blood-draw technology has received CE Mark (Conformite Europeenne), a significant confirmation of medical device quality from the European Union. This regulatory milestone further validates the...

09:32
Pressure BioSciences, Inc. ("PBI" and the "Company"), a leader in the development and sale of broadly enabling, pressure cycling technology ("PCT")-based sample preparation solutions to the worldwide life sciences industry, today announced that...

08:00
Pediatric researchers have discovered gene locations affecting bone strength in wrist bones, the most common site for fractures in children. Children who have those genetic variants may be at higher-than-average risk of wrist fractures, and could...

08:00
VirtualScopics, Inc. , a leading provider of clinical trial imaging solutions, along with IXICO plc (AIM: IXI), the brain health company, announced today the alliance has been awarded contracts with two top 15 pharmaceutical companies, one in...

08:00
ReadSense, a genomics company at nanocenter TECHNOSPARK (Troitsk), and Strand Life Sciences, the world leader in the implementation of bioinformatics in personalized medicine, have signed a cooperation memorandum. According to the memorandum, Strand...

1 2 3 4 5 6 7 8 9 10